UPDATE: The grants have now been awarded. CAAT would like to extend congratulations to all applicants. Full details here.
GranteesChristine Bear
Senior Scientist, Programme in Molecular Medicine
Hospital for Sick Children
Development of a platform for SARS-CoV-2 therapy testing and development using primary nasal epithelial cultures Parastoo Khoshakhlagh
Co-founder, President and CEO, GC Therapeutics, Inc.
Investigating the effects of hypertension drugs on the Infectivity of SARS-CoV-2 in synthetically accelerated vascularized type II pneumocyte-containing pulmonary organoids In response to the global COVID-19 pandemic, the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) at the Bloomberg School of Public Health is redirecting part of our grant program to help accelerate the discovery of mechanisms, medicines, and vaccines for COVID-19. Our goal is to centralize information and stimulate funding of the development of non-animal, human biology-based models to help coordinate and accelerate response to current and emerging pandemics. CAAT has always relied on the expertise and advice of its stakeholders and advisors, and—particularly in times like of global crisis—believes that we need to act together. Viral pandemics are going to be stopped and conquered only with global cooperation. In light of the current public health emergency, we are announcing the dedication of a portion of the Alan and Helene Goldberg In Vitro Toxicology Grants to development of tools to address the emerging health threats. This new initiative is our Fast-track grant for research on non-animal approaches to investigate mechanisms, medicines, and vaccines for coronaviruses. We would like to thank Animalfree Research and Humane Society International/Humane Society of the United States for their generous support of these grants. Applications for this grant will be screened by an advisory committee and will be funded as soon as possible. The application deadline is April 30th 2020. CALL TO ACTION: Please consider supporting our COVID-19 grants with a financial donation. If you are interested in supporting this fast-track grant, please contact Camila Januario.
CRITERIA: Type of organization: academic group, non-profit, or small or medium enterprise Location: Global Types of technology: human cells, computational approaches, or other non-animal methods (no animal models or animal-origin tissues) Amount: up to $40,000 Grant advisory committee: CAAT staff and advisory board Download Grant Application Kit (PDF) and Grant Application Form (PDF) | 
